Optic disk and retinal nerve fiber layer damage after transient central retinal artery occlusion: An experimental study in rhesus monkeys

American Journal of Ophthalmology

Volumn 129, Issue 6, 2000, Pages 786-795

  Hayreh, Sohan Singh ^a   Jonas, Jost B ^b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCEIN;

AGE; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY CLAMP; ARTICLE; ATHEROSCLEROSIS; CENTRAL RETINA ARTERY OCCLUSION; COLOR; CONTROLLED STUDY; EYE FUNDUS; FLUORESCENCE ANGIOGRAPHY; HYPERTENSION; MORPHOMETRICS; NERVE FIBER; NONHUMAN; OPTIC DISK; OPTIC NERVE; OPTIC NERVE LESION; PHOTOGRAPHY; PRIORITY JOURNAL; RETINA NERVE CELL; RHESUS MONKEY; STEREOSCOPIC VISION;

ANIMALS; ARTERIOSCLEROSIS; FLUORESCEIN ANGIOGRAPHY; FUNDUS OCULI; HYPERTENSION; MACACA MULATTA; NERVE FIBERS; OPTIC ATROPHY; OPTIC DISK; PHOTOGRAPHY; RETINAL ARTERY OCCLUSION; RETINAL DISEASES; RETINAL GANGLION CELLS; TIME FACTORS;

EID: 0033852953     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(00)00384-6     Document Type: Article

References (29)

1. von Graefe A. Über Embolie der Arteria centralis retinae als Ursache plötzlicher Erblindung. Graefes Arch Ophthalmol. 5:1859;136-157.
2. Hayreh S.S., Kolder H.E., Weingeist T.A. Central retinal artery occlusion and retinal tolerance time. Ophthalmology. 87:1980;75-78.
3. Hayreh S.S., Weingeist T.A. Experimental occlusion of the central artery of the retina. I. Ophthalmoscopic and fluorescein fundus angiographic studies. Br J Ophthalmol. 64:1980;896-912.
4. Hayreh S.S., Weingeist T.A. Experimental occlusion of the central artery of the retina. IV. Retinal tolerance time to acute ischaemia. Br J Ophthalmol. 64:1980;818-825.
5. Hayreh S.S. Retinal and optic nerve head ischemic disorders and atherosclerosis - role of serotonin. Progr Ret Eye Res. 18:1999;191-221.
6. Hayreh S.S., Servais G.E., Virdi P.S., Marcus M.L., Rojas P., Woolson R.F. Fundus lesions in malignant hypertension III. Arterial blood pressure, biochemical, and fundus changes. Ophthalmology. 93:1986;45-59.
7. Hayreh S.S., Piegors D.J., Heistad D.D. Serotonin induced constriction of ocular arteries in atherosclerotic monkeys implications for ischemic disorders of retina and optic nerve head . Arch Ophthalmol. 115:1997;220-228.
8. Hayreh S.S., Jonas J.B., Zimmerman M.B. Parapapillary chorioretinal atrophy in chronic high-pressure experimental glaucoma in rhesus monkeys. Invest Ophthalmol Vis Sci; 39:1998;2296-2303.
9. Jonas J.B., Schiro D. Normal retinal nerve fiber layer visibility correlated to rim width and vessel caliber. Graefe's Arch Clin Exp Ophthalmol. 231:1993;207-211.
10. Hayreh S.S. Blood supply of the optic nerve head and its role in optic atrophy, glaucoma and oedema of the optic disc. Br J Ophthalmol. 53:1969;72l-748.
11. Hayreh S.S., van Heuven W.A.J., Hayreh M.S. Experimental retinal vascular occlusion I. Pathogenesis of central retinal vein occlusion. Arch Ophthalmol. 96:1978;3ll-323.
12. Petrig B.L., Riva C.E., Hayreh S.S. Laser Doppler flowmetry and optic nerve head blood flow. Am J Ophthalmol. 127:1999;413-425.
13. Singh S., Dass R. The central artery of the retina II. Distribution and anastomoses. Br J Ophthalmol. 44:1960;280-299.
14. Dixon K.C. Ischaemia and the neurone. Adams C.W.M. Neurohistochemistry. 1965;558-598 Elsevier, New York.
15. Hayreh S.S. The 1994 Von Sallman Lecture the optic nerve head circulation in health and disease . Exp Eye Res. 61:1995;257-272.
16. Singh S., Dass R. The central artery of the retina I. Origin and course. Br J Ophthalmol. 44:1960;193-212.
17. Vine A.K., Maguire P.T., Martonyi C., Kincaid M.C. Recombinant tissue plasminogen activator to lyse experimentally induced retinal arterial thrombi. Am J Ophthalmol. 105:1988;266-270.
18. Bertram B, Wolf S, Fisches H, Schulte K, Hoberg A, Reim M. Lysebehandlung bei retinalen Arterienverschlussen mit Plasminogen-Aktivator. Klin Monatsbl Augenheilkd 1991;198:295-300.
19. Schmidt D., Schumacher M., Wakhloo A.K. Microcatheter urokinase infusion in central retinal artery occlusion. Am J Ophthalmol. 113:1992;429-434.
20. Vulpius K, Hoh H, Lange H, Maercker W, Ruhle H. Selektive perkutane transluminale Lysetherapie mit RTPA bei retinalem Zentralarterienverschluss. Ophthalmologe 1996;93:149-153.
21. Weber J., Remonda L., Mattle H.P., et al. Selective intra-arterial fibrinolysis of acute central retinal artery occlusion. Stroke. 29:1998;2076-2079.
22. Richard G., Lerche R.-C., Knospe V., Zeumer H. Treatment of retinal arterial occlusion with local fibrinolysis using rTPA. Ophthalmology. 106:1999;768-773.
23. Hayreh S.S. Retinal arterial occlusion with LIF using rTPA. Ophthalmology. 106:1999;1236-1238.
24. Thrombolytic therapy with streptokinase in acute ischemic stroke. NEJM. 335:1996;145-150.
25. Donnan G.A., Davis S.M., Chambers B.R., et al. Australian Streptokinase (ASK) Trial Study Group streptokinase for acute ischemic stroke with relationship to time of administration . JAMA. 276:1996;961-966.
26. Barth H, Stein H, Fasse A, Mehdorn HM. Intrazerebrale Blutung nach systemischer Thrombolyse bei Patienten mit Verschluss der A. centralis retinae. Bericht über 2 Fälle. Ophthalmologe 1996;93:739-744.
27. Bendzsus M., Urbach H., Ries F., Solymosi L. Outcome after local intra-arterial fibrinolysis compared with the natural course of patients with a dense middle cerebral artery on early CT. Neuroradiology. 40:1998;54-58.
28. Jonas J.B., Hayreh S.S. Optic disc morphology in experimental central retinal artery occlusion in rhesus monkeys. Am J Ophthalmol. 127:1999;523-530.
29. Jonas J.B., Xu L. Optic disc morphology in eyes after nonarteritic anterior ischemic optic neuropathy. Invest Ophthalmol Vis Sci. 34:1993;2260-2265.